ARCHIVES

Oral UFT Equivalent To FULV In Stage II and III Colon Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 7 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

October 25, 2013

Peers Puzzled By Herberman’s Stance On Cell Phones While Believers Rally.

August 1, 2008

Agriculture Dept. Asks clearinghouse To Consider Broader Risk Assessment Data

July 14, 1978

FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA

October 19, 1979

In Brief: Morgan Named Director Of UAMS Myeloma Institute

April 25, 2014

Targeting Men At High Risk Finds More Head & Neck Cancer

September 24, 2010